Generic Drugmakers Back Ruling Against Tribal Immunity For Patent Reviews
WASHINGTON, D.C. — A case in which a drugmaker is trying to use an Indian tribe’s sovereign immunity to shield it from inter partes review (IPR) of its patents is a...To view the full article, register now.
Already a subscriber? Click here to view full article